Passage Bio Welcomes Dolan Sondhi, Ph.D. to Board Of Directors - Passage Bio (NASDAQ:PASG)

PHILADELPHIA, July 31, 2023 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ:PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS)

Related Keywords

University Of Pennsylvania ,Pennsylvania ,United States ,Philadelphia ,Delhi ,India ,Tom Woiwode ,Stuart Henderson ,Dolan Sondhi ,Thomas Woiwode ,William Chou ,Mike Beyer ,Professor Of Research ,Stephens College ,Delhi University ,Passage Bio Inc ,Healthcare Communications ,Brown University ,University Of Pennsylvania Gene Therapy Program ,Sam Brown Inc ,Corporate Governance Committee ,Corporate Governance ,Genetic Medicine ,Weill Cornell ,Managing Director ,Passage Bio ,Gene Therapy Program ,